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ABSTRACT
Three hormone receptors, the estrogen receptor
(ER), the androgen receptor (AR) and glucocorticoid
receptor (GR) play an important role in regulating
the cellular differentiation tissue development
of skin, bone, the brain and the endocrine system;
therefore, there is a strong scientific need to identify
and characterize hormone receptor transcriptional
regulation. Given that the vast amount of regulatory
data for hormone being produced by ChIP-based
high-throughput experiments is widely scattered
in disparate, poorly cross-indexed data stores,
a flexible platform for organizing and relating
these data would provide significant value. We
created a data management system called the
Hormone Receptor Target Binding Loci, HRTBLDb
(http://motif.bmi.ohio-state.edu/hrtbldb), to address
this problem. This database contains hormone
receptor binding regions (binding loci) from in vivo
ChIP-based high-throughput experiments as well
as in silico, computationally predicted, binding
motifs and cis-regulatory modules for the
co-occurring transcription factor binding motifs,
which are within a binding locus. It also contains
individual binding sites whose regulatory action
has been verified by in vitro experiments. The
current version contains 44673 binding elements
with 114 hormone response elements which are
verified by in vitro experiments; 75 binding motifs
which occur with a hormone response element
and whose co-regulatory action is verified by
in vitro experiments; 18472 binding loci from
in vivo experiments; and 26012 computationally
predicted binding motifs.
INTRODUCTION
Hormone receptors (HRs) are steroid hormone activated
transcription factors which are a part of the nuclear
receptor super-family consisting of >60 members. Three
hormone receptors, the estrogen receptor (ER), the
androgen receptor (AR) and glucocorticoid receptor
(GR) play an important role in regulating the cellular dif-
ferentiation tissue development of skin, bone, the brain
and the endocrine system (1). Many studies (2–4) have
shown that all three of HRs regulates gene expression
for many signiﬁcant phenotypes. Dysregulation of any
of these hormone signaling pathways is linked to many
diﬀerent types of diseases. For example, malignancy of
the ER has been associated with endocrine diseases such
as breast and prostate cancers, and the action of ERs is
linked to the growth promotion and invasion of breast
cancer cells (5). Dysregulation in the production of
androgens can aﬀect diﬀerent organ systems, in which it
caused the diseases such as androgen insensitivity
syndromes, prostate cancer, hepatocellular carcinomas,
acne and male pattern alopecia (6,7). GR activation is
often associated with inducing apoptosis in lymphocytes
and lymphomas, and paradoxically inhibiting the
apoptotic response to several cell stressors including
growth factor withdrawal (8) in breast cancer cell lines.
HRs modulate the transcription of target genes through
hormone activation, and they do so either through (i)
direct binding, in which HRs directly bind to hormone
response elements; (ii) indirect binding, where HRs
interact with other transcription factors, which instead
bind to the DNA themselves; or (iii) co-occurrent
binding, where HRs bind with lower aﬃnity to DNA
binding sequences and interact with other TFs through
co-regulators. These modes of binding are shown at
http://motif.bmi.ohio-state.edu/hrtbldb. ARs bind to the
androgen response element 50-GGAACAnnnTGTTCT-30
(9), ERs bind with the highest aﬃnity to the estrogen
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ACCT-30 (10), and GRs bind to the glucocorticoid
response element 50-GTTACAnnnTGTTCT-30 (11).
Since hormone receptors are key regulators of growth,
diﬀerentiation and metabolism in multiple organs, the
characterization of the transcriptional regulation of
their target genes is quite important. Several new high-
throughput technologies such as ChIP-chip (12,13),
ChIP-seq (14,15) and ChIP-PET (16) are producing a
large amount of whole-genome-wide hormone receptor
regulatory data, in many diﬀerent cell types and tissues
[see Supplementary Table S1 for all literature as well as
(17)]. Integrating these data into a single resource will
allow expedited cross-reference, literature discovery and
aid in the validation of novel data. To that end we have
created a database called the Hormone Receptor Target
Binding Loci, HRTBLDb. This database mainly contains
in vivo binding loci identiﬁed from ChIP-based high-
throughput technologies and computationally predicted
binding motifs and the cis-regulatory modules for the
binding loci. It also collected in vitro experimentally
deﬁned binding elements. The data visualization focuses
on a whole-genome-wide scale rather than traditional
promoter regions and is accessed through simple yet
expressive data ﬁltering.
DATABASE CONTENT
In the current version of our HRTBLDb database, it
contains two types of data, (i) in vitro binding elements,
which were experimentally veriﬁed in vitro to bind one of
the three hormone receptors using either EMSA or ChIP
assays; (ii) in vivo binding loci identiﬁed from the ChIP-
based high-throughput data using our peak detecting
programs fdrPeak (18) for the ChIP-chip data and
BELT (X. Lan et al., manuscript in preparation) for the
ChIP-seq data, and binding motifs underneath of the
binding loci using our ChIPMotifs (19) as well as
cis-regulatory modules identiﬁed by our ChIPModules
program (20). The database contains the nucleotide
sequence for every indexed binding site. For experimen-
tally veriﬁed binding sites, the sequence and coordinates
given in the paper are used when possible. In papers for
which the sequence is not given, the coordinates given in
the paper were used to obtain the sequence from the
genome speciﬁed in the paper. For predicted binding
sites, the sequence was taken from the genome used in
the database for that species by the predictive algorithm
used, after the coordinates from the paper were converted
from the genome used in the paper to the version used in
the database. For simplicity, the database only contains
the annotation for one genome assembly per species. The
human assembly used is HG18, and data was taken from
papers in the HG18 and HG17 assemblies: HG17 data
was converted to HG18 using UCSC’s liftOver program.
Mouse data is in the MM8 assembly, and rat data is in the
RN4 assembly. The HRTBLDb contains AR, ER and GR
in vitro data for all three species; however, all of the in vivo
data is human. The total number of diﬀerent data and
sources by hormone receptor is shown in Figure 1.
DATABASE IMPLEMENTATION
The database is designed to have a close mapping to the
real objects that it represents (Supplementary Data, and
the web site http://motif.bmi.ohio-state.edu/hrtbldbabout
#schema). One beneﬁt of this is that entries in the database
express the natural relationships between their real world
counterparts. This was done to make complex queries to
the database simpler and more intuitive. Since the
database stores in vivo ChIP-based data, with computa-
tionally predicted binding motifs, and in vitro experimen-
tally veriﬁed individual binding motifs, these data were
split into two separate entities, binding loci and binding
motifs. ChIP-based experiments produce many larger
regions on the chromosome without ﬁne interior details,
aside from predicted binding sites; therefore, these regions
are stored in a separate table, Loci. Both the predicted
binding motifs within binding loci and the experimentally
veriﬁed binding motifs are stored in the Binding Sites
table. Each locus and binding site is also associated with
an entry in the Experiments table which contains the
meta-data common to all data from a given resource,
reference information for the scientiﬁc paper, cell line,
hormone receptor, etc. The database supports the separa-
tion of all data by species; however, for speed and eﬃ-
ciency, no meta-data on the species is stored in the
database.
Binding loci have a one-to-many relationship with
binding sites: i.e. a locus contains multiple binding sites,
but no binding site is a part of more than one locus, if any.
Overlapping loci from diﬀerent experiments may share
common predicted binding sites; however, these are rep-
resented as separate entities in the database. Each binding
site is a collection of information about a single predicted
or experimentally veriﬁed transcription factor binding site.
They contain the coordinates, name and the exact
sequence of that individual binding site. Loci and
Binding are associated with a single ‘nearest gene’,
which is the gene whose 50-o r3 0-end is nearest to the
mid-point of that loci. Based on its proximity to this
gene they are labeled with a region, which is a short
description of its location relative to the gene, such as
‘within gene’, ‘50-promoter’, ‘30-distal’, etc. For the
details of the distances from the gene that each region
represents and how they are calculated, see Supplementary
Data and our web site http://motif.bmi.ohio-state.
edu/hrtbldbabout#regions. The publications which were
used as data sources are recorded in the experiments
table; however, there is a one-to-many mapping between
source publications and experiment entries. Each experi-
ment entry represents a combination of a publication,
a species, a cell line and an experimental method. If one
publication has datasets for which these characteristics
diﬀer, there will be one experiment entry for each dataset.
This database is implemented in MySQL using the
MyISAM engine. All of the data are available for
download as either a MySQL dump or as collection
of tab separated text ﬁles, along with the database
schema and the queries used to implement the schema,
at the web site http://motif.bmi.ohio-state.edu/hrtbldb
/downloads.
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We have developed a data visualization tool, the Portable
Epigenetic Regulator Framework (PEGRF, Figure 2); it
is a comprehensive, highly modular application for the
storage of genomic and epigenomic data, data search
and graphical display, all over the internet, through a
web browser. The graphical rendering is done using the
PHP light-weight regulator visualization tool (PLRVT),
a module to PEGRF which we developed in tandem.
Both are implemented entirely in the PHP scripting
language and run on a web server. The primary beneﬁts
of this approach are that the application is both operating
system and database agnostic. This results in PEGRF
being highly portable across a wide variety of systems,
and easily integrated into the existing web presence for
many organizations (Supplementary Data).
There are multiple methods of searching through the
data in the HRTBLDb. The simplest, ‘Basic Search’, is
similar to the search engine of UCSC genome browser
in that a location on the genome in the format
chrX:0000–9999 is entered to view all data in the
database within that region. Basic search also supports
the display of all data near the transcription start site of
a gene searched for by its gene symbol, RefSeq ID or its
GenBank Gene ID. For example, a search results for the
region of chr19:56047091–56052091 shows KLK3 (PSA)
gene has both in vitro validated androgen response
element and the predicted androgen response element
from in vivo ChIP-chip AR-binding loci in the same
location. The more complex search, ‘Advanced Search’,
ﬁlters the data in the database by various criteria. The
data is ﬁltered by species and experimental type in all
searches. The experimental types are divides ﬁrst
between ‘in vivo’ and ‘in vitro’ techniques. Within in vivo,
one can further ﬁlter the results by the type of in vivo
technique used. The results may then be further ﬁltered
by the cell line used in the experiment and/or the hormone
receptor whose binding was being measured. A ‘Basic
Search’ takes the user directly to a visualization of the
target region of the genome and all of the data in the
database within that region; whereas, an ‘Advanced
Search’ shows a list of all the binding elements that meet
the speciﬁed criteria which may be browsed and then
selected for visualization of the target element and all
elements near it.
The data visualization is of a region on a chromosome
in a single genome assembly. All of the data in the
database is shown graphically to give their relative
spatial relationships, and all of the details of each
element are tabularized below the graphical visualization
for further examination or export. This visualization is the
only mechanism to display the binding elements spatially
near a given element on the chromosome. Each data
source is given a separate track in the visualization, and
the data elements from it are described in detail in a source
speciﬁc table below the visualization in the order they are
displayed. The data visualization also provides a way to
visually browse the genome for target data by moving the
region being displayed up or down the chromosome and
zooming in and out to see more or less data (Figure 3).
DISCUSSION
The HRTBLDb is a comprehensive data management
system for the aggregation, discovery and analysis of
hormone receptor binding sites in the mammalian
genomes including human, mouse and rat. Given that its
primary purpose is to allow other researchers to build
upon the information generated by high-throughput
experiments, the current version contains 44673 binding
in vitro in vivo
Human Mouse Rat Human
ER 67 4 5 16,502
AR 20 2 3 1,819
GR 3 3 7 151
B
A
Figure 1. (A) The number of experimentally conﬁrmed in vitro direct and indirect binding sites in comparison with the high-throughput in vivo
binding loci. (B) A summary of the number of publications in the database by hormone receptor and experimental type.
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veriﬁed in in vitro experiments; 75 binding motifs which
occur with a hormone response element and whose
co-regulatory action is veriﬁed in in vitro experiments;
18472 binding loci from in vivo experiments; and 26012
computationally predicted binding motifs.
The ﬁrst of several distinguishing features is that
HRTBLDb is focused on a whole-genome-wide scale
of HR regulatory information and classiﬁes the binding
sites based on their proximity to genes from RefGene
databases, such as HG18 RefSeq, MM8 RefSeq and
RN4 RefSeq (http://genome.ucsc.edu/). The importance
of this feature is that it accommodates new conclusions
from the ENCODE consortium (21) that transcription
factor binding sites may be located anywhere in the
human genome (See the Supplementary Data and the
web site http://motif.bmi.ohio-state.edu/hrtbldbabout
#regions for the classiﬁcation scheme used). The second
feature is that we not only collected the binding loci
identiﬁed from in vivo high-throughput data, but also
computationally predicted binding motifs which the TFs
could possibly bind to and cis-regulatory modules for
co-occurrent binding with other TFs. The third feature
is that, to adequately verify the regulatory mechanisms
at work on several genes in our database, we included
direct and indirect binding patterns from in vitro EMSA
and ChIP assay experiments. These patterns show regula-
tory action along with the reported motifs where available
and publication references. For example, cathepsin D
(CTSD) is reported to be involved with a direct binding
estrogen response element in (22) and an endrogen
response element and SP1 indirect binding in (23); there-
fore, this data was added to our database for comparison
with in vivo binding data. In summary, the abundance of
data in our HRTBLDb will hopefully contribute toward
the progression of the ongoing investigation in to HR gene
regulation and its mechanisms.
Although we have migrated all the data from our
previous ERTargetDB (24) into our new database, there
are signiﬁcant diﬀerences between two databases: (i)
HRTBLDb focuses on whole-genome-wide binding sites
and visualization; whereas, ERTargetDB only contained
promoter regions; (ii) The new database contains data for
three major hormone receptors (ER, androgen receptor
and GR). It contains binding loci from both in vivo
ChIP-based high-throughput data and in vitro experimen-
tally validated binding motifs from EMSA and ChIP
assay; (iii) it will display all possible binding sites, diﬀerent
types of experiment, HRs and cell lines, in the queried
region; (iv) the visualization is done by a modular
binding element visualization tool we developed in
tandem, the PHP light-weight regulator visualization
tool (PLRVT) and ERTargetDB uses the GDVTK tool
written in Java; and (v) the internal database schema are
diﬀerent as well in that the HRTBLDb is designed to be
generic and store many diﬀerent forms of DNA-binding
elements for present and future research. We should also
point out that our HRTBLDb is diﬀerent from other
similar publicly available databases, such as MRbase
and NuReBase (25), which both contain the chemical
and biological properties of hormones and their receptors,
focus on all properties of nuclear receptors and their data
are manually collected, hence these databases include a
limited amount of information, but our database focuses
on a subset of hormone receptors and their targets’ infor-
mation and uses computational processing to predict addi-
tional binding motifs and transcriptional regulatory
modules. This information can provide direction for
future research which would likely be fruitful. Our
software used to make these binding motif predictions
are published on genome research, ChIPMotifs (19) for
identiﬁed binding motifs as well as ChIPModules (20)
for identiﬁed cis-regulatory modules. Ours is diﬀerent
from ERGDB (26) and KBERG (27) which were
Figure 2. A data ﬂow diagram showing the movement of data from our data sources (publications) through the formatting process, to the system
and into the database; likewise, it shows the movement of input from the user to the system and the resulting output to the user’s web browser both
as text and through the graphical sub-system, PLRVT.
Nucleic Acids Research, 2010,Vol.38, Database issue D679developed by the same group. Their databases only focus
on ER responsive genes, and functional classiﬁcations,
gene expression data. We think ChIP-based data with
direct targets, can help determine transcriptional regula-
tory networks, therefore we created the HRTBLDb.
As part of the Integrative Cancer Biology Program of
the National Cancer Institute (28), we have developed
a ChIP-seq-based computational method to characterize
the epigenetic mechanisms involved in the target genes of
the ER pathway (J. Wu et al., manuscript in preparation).
The generated ER target-binding loci have been deposited
into this database. We will add epigenetic regulatory data
such as DNA methylation and histone modiﬁcation
patterns across the loci for these HRs to the database in
the future. Other hormone receptors data such as the
progesterone receptor are also planned to be added to
our database in the near future.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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